Gabapentin
NDC 82619-146, Gabapentin, tablet, from Creekwood Pharmaceuticals LLC.
- Product NDC
- 82619-146
- Status
- Listed
- Labeler
- Creekwood Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205101
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82619-146 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN800 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82619-146-01 | 82619014601 | 100 TABLET in 1 BOTTLE (82619-146-01) |
| 82619-146-02 | 82619014602 | 500 TABLET in 1 BOTTLE (82619-146-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/266ef369-0a56-f225-e063-6294a90a495e
Use it
Look up 82619-146 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82619-146 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82619-146. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.